Download presentation
Presentation is loading. Please wait.
Published byRuth Carson Modified over 6 years ago
1
Figure 1 Flow chart showing the selection of publications identified in the literature search.
From: GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type Hum Reprod Update. 2017;23(5): doi: /humupd/dmx017 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please
2
Figure 3 Ongoing pregnancy rate per patient population.
From: GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type Hum Reprod Update. 2017;23(5): doi: /humupd/dmx017 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please
3
Figure 2 Funnel plot of publications that reported ongoing pregnancy rate.
From: GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type Hum Reprod Update. 2017;23(5): doi: /humupd/dmx017 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please
4
Figure 4 Ongoing pregnancy rate per antagonist per flexible or fixed protocol with or without oral hormonal programming (OHP) in a general IVF population. From: GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type Hum Reprod Update. 2017;23(5): doi: /humupd/dmx017 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please
5
Figure 5 Clinical pregnancy rate per patient population.
From: GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type Hum Reprod Update. 2017;23(5): doi: /humupd/dmx017 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please
6
Figure 6 Number of oocytes retrieved per patient population.
From: GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type Hum Reprod Update. 2017;23(5): doi: /humupd/dmx017 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please
7
Figure 7 Ovarian hyperstimulation syndrome (OHSS) rate per patient population.
From: GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type Hum Reprod Update. 2017;23(5): doi: /humupd/dmx017 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please
8
Figure 8 Live birth rates per patient population.
From: GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type Hum Reprod Update. 2017;23(5): doi: /humupd/dmx017 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.